Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
HCDI - Harbor Custom Development Inc - Stock Price Chart
TickerHCDI [NASD]
CompanyHarbor Custom Development Inc
CountryUSA
IndustryReal Estate - Development
Market Cap2.61MEPS (ttm)-38.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-63.47%
P/S0.07EPS next 5Y-
P/B-EPS Q/Q-1.34%
Dividend-Sales Q/Q-52.88%
Insider Own6.89%Inst Own9.14%
Insider Trans0.00%Inst Trans-43.44%
Short Float2.09%EarningsAug 14/b
Analyst Recom1.00Target Price160.00
Avg Volume114.84K52W Range0.65 - 15.85
Sep-22-23 03:00PM Harbor Custom Development, Inc., Announces Board of Directors Resignation (GlobeNewswire) +5.53%
Aug-21-23 11:06AM HCDI: Harbor Custom Development reports 2nd quarter 2023 results and updates investor community on project status and the current real estate market environment. (Zacks) -7.50%
Aug-16-23 12:30PM Harbor Custom Development, Inc., Announces 17 Luxury Homes Coming to the Horseshoe Bay and Austin MSAs (GlobeNewswire)
Aug-15-23 09:30AM Harbor Custom Development, Inc., Now Leasing Meadowscape Apartments in Olympia, WA (GlobeNewswire) -8.51%
Aug-14-23 09:30AM Harbor Custom Development, Inc. Reports 2023 Second Quarter and Year to Date Financial Results (GlobeNewswire) -9.02%
Aug-02-23 02:30PM Harbor Custom Development, Inc., Announces Date of Second Quarter 2023 Earnings Release and Presentation (GlobeNewswire)
Jul-18-23 10:05AM Harbor Custom Development, Inc., Promotes New Leadership Team (GlobeNewswire)
Jul-13-23 01:20PM Harbor Custom Development, Inc., Announces Interim CEO at the Annual Meeting of Shareholders (GlobeNewswire)
Jul-06-23 09:30AM Harbor Custom Development, Inc., Secures $19,950,000 Loan with Sound Capital to Refinance Belfair View Apartment Project (GlobeNewswire)
Jun-26-23 05:00PM Harbor Custom Development, Inc. Announces Change in Executive Leadership (GlobeNewswire)
NEXI - Neximmune Inc - Stock Price Chart
TickerNEXI [NASD]
CompanyNeximmune Inc
CountryUSA
IndustryBiotechnology
Market Cap6.41MEPS (ttm)-267.72
P/E-EPS this Y63.85%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-40.76%
P/S-EPS next 5Y-
P/B0.03EPS Q/Q-1458.48%
Dividend-Sales Q/Q-
Insider Own37.79%Inst Own16.11%
Insider Trans-1.92%Inst Trans-78.11%
Short Float0.99%EarningsAug 10/a
Analyst Recom1.00Target Price125.00
Avg Volume23.42K52W Range1.25 - 20.35
Dec-01-23 01:34PM NEXI Stock Halted: What's Going on With NexImmune Shares Today? (InvestorPlace) +143.95%
08:38AM Why Is NexImmune (NEXI) Stock Up 353% Today? (InvestorPlace)
Nov-06-23 08:54AM Why Is NexImmune (NEXI) Stock Down 10% Today? (InvestorPlace) -5.80%
Oct-24-23 08:00AM NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes (GlobeNewswire)
Oct-19-23 08:00AM NexImmune Announces Presentations at The Society for Immunotherapy of Cancers 38th Annual Meeting (GlobeNewswire) -20.00%
Oct-18-23 11:30AM NexImmune Announces 1-for-25 Reverse Stock Split (GlobeNewswire) -19.00%
Aug-31-23 04:45PM NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy (GlobeNewswire)
Aug-10-23 04:01PM NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Jun-05-23 08:01AM NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-HSCT AML at the American Society of Clinical Oncology 2023 Annual Meeting (GlobeNewswire)
May-22-23 04:01PM NexImmune Announces Poster Presentation at the 2023 FOCIS Annual Meeting (GlobeNewswire) +7.73%
VIEW - View Inc. - Stock Price Chart
TickerVIEW [NASD]
CompanyView Inc.
CountryUSA
IndustryBuilding Products & Equipment
Market Cap4.19MEPS (ttm)-67.86
P/E-EPS this Y48.13%
Forward P/E-EPS next Y56.91%
PEG-EPS past 5Y-
P/S0.03EPS next 5Y-
P/B-EPS Q/Q-13786.02%
Dividend-Sales Q/Q60.85%
Insider Own33.26%Inst Own35.96%
Insider Trans-29.60%Inst Trans-58.21%
Short Float5.72%EarningsNov 14/a
Analyst Recom3.00Target Price180.00
Avg Volume73.05K52W Range0.62 - 95.40
Nov-15-23 09:33AM View, Inc. (NASDAQ:VIEW) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.90%
Nov-14-23 04:20PM RXR Selects View Smart Windows for 89 Dekalb Avenue in Brooklyn, NY, the Second RXR Multifamily Development to Feature View (GlobeNewswire) +33.08%
04:15PM View Announces Q3 2023 Earnings (GlobeNewswire)
Nov-09-23 07:00AM View to Release Third Quarter 2023 Financial Results Tuesday, November 14th (GlobeNewswire)
Oct-30-23 07:00AM View, Inc. Adds Tridium's Niagara to View Secure Edge Marketplace (GlobeNewswire) -14.02%
Oct-16-23 07:30AM View Announces $50 Million Financing with Strategic Real Estate Investors (GlobeNewswire)
Aug-10-23 04:15PM View Announces Q2 2023 Earnings (GlobeNewswire) -10.83%
04:10PM View Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jul-31-23 08:29PM View to Release Second Quarter 2023 Financial Results Thursday, August 10th (GlobeNewswire) -27.78%
Jul-27-23 05:55AM View, Inc. Completes Reverse Stock Split (GlobeNewswire) +44.36%
NLSP - NLS Pharmaceutics Ltd - Stock Price Chart
TickerNLSP [NASD]
CompanyNLS Pharmaceutics Ltd
CountrySwitzerland
IndustryBiotechnology
Market Cap19.78MEPS (ttm)-0.84
P/E-EPS this Y0.00%
Forward P/E-EPS next Y-18.42%
PEG-EPS past 5Y-16.06%
P/S-EPS next 5Y-
P/B6.03EPS Q/Q40.87%
Dividend-Sales Q/Q-
Insider Own38.48%Inst Own29.11%
Insider Trans0.00%Inst Trans-38.63%
Short Float0.52%Earnings-
Analyst Recom3.00Target Price4.00
Avg Volume140.85K52W Range0.26 - 1.88
Dec-01-23 07:30AM NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc. (ACCESSWIRE) +45.27%
Nov-28-23 07:30AM NLS Pharmaceutics Announces Election of Additional Board Members (ACCESSWIRE)
Nov-27-23 08:30AM NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia (ACCESSWIRE)
Nov-16-23 08:00AM NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan (ACCESSWIRE) -34.44%
Oct-25-23 04:30PM NLS Pharmaceutics Announces Receipt of Nasdaq Minimum Bid Price Notification (ACCESSWIRE) -7.14%
Oct-19-23 05:00PM NLS Pharmaceuticals to Reschedule Company Update on Strategic Discussions (ACCESSWIRE)
Oct-12-23 09:40AM NLS Pharmaceutics Announces Company Update on Strategic Partnerships (ACCESSWIRE) -12.63%
Aug-28-23 07:30AM NLS Pharmaceutics CEO Issues Letter to Shareholders (ACCESSWIRE) +9.63%
Jul-03-23 07:00AM NLS Pharmaceutics to Proceed with Phase 3 Clinical Program (AMAZE) for Mazindol ER for the Treatment of Narcolepsy Following FDA Review and IRB Approval of the Full Study Protocol (ACCESSWIRE) +9.09%
Jun-30-23 04:05PM NLS Pharmaceutics Releases the Results from its Annual General Meeting (ACCESSWIRE) +19.57%
GGE - Green Giant Inc - Stock Price Chart
TickerGGE [NASD]
CompanyGreen Giant Inc
CountryChina
IndustryReal Estate - Development
Market Cap17.01MEPS (ttm)-3.98
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.10EPS next 5Y-
P/B0.51EPS Q/Q-4493.79%
Dividend-Sales Q/Q-63.06%
Insider Own32.27%Inst Own0.04%
Insider Trans0.00%Inst Trans-
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume1.39M52W Range0.16 - 3.42
Dec-01-23 08:21AM Why Is Green Giant (GGE) Stock Up 81% Today? (InvestorPlace) +66.43%
Nov-09-23 05:31PM B&G Foods, Inc. (NYSE:BGS) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.34%
05:52AM B&G Foods sells Green Giant US canned vegetable line to Seneca Foods (Food Dive)
Nov-08-23 06:28PM B&G Foods Inc (BGS) Reports Mixed Q3 Results Amid Portfolio Reshaping Efforts (GuruFocus.com) -17.04%
Oct-05-23 04:00PM Green Giants: The 3 Best ESG Stocks for a Sustainable Portfolio (InvestorPlace)
Mar-02-23 09:37AM Green Giant Energy Texas and ACE Green Recycling Plan to Develop Lithium-ion Recycling Facility in Texas (PR Newswire)
Mar-01-23 09:25AM Q4 2022 B&G Foods Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-03-23 09:30AM Green Giant Inc. announces opening of its Texas office as the base for its planned green energy business office (PR Newswire)
Nov-14-22 09:35AM GGE announces the appointment of a CEO of its US Subsidiary to lead the effort to explore green energy sector (PR Newswire)
QCON - American Century Quality Convertible Securities ETF - Stock Price Chart
TickerQCON [AMEX]
CompanyAmerican Century Quality Convertible Securities ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend2.94%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.41K52W Range38.06 - 41.72
POLA - Polar Power Inc - Stock Price Chart
TickerPOLA [NASD]
CompanyPolar Power Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap5.90MEPS (ttm)-0.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-42.15%
P/S0.33EPS next 5Y-
P/B0.40EPS Q/Q23.15%
Dividend-Sales Q/Q11.95%
Insider Own43.64%Inst Own6.20%
Insider Trans0.00%Inst Trans-3.17%
Short Float5.89%EarningsAug 14/a
Analyst Recom1.00Target Price25.00
Avg Volume20.28K52W Range0.73 - 2.25
Dec-01-23 09:12AM Why Is Polar Power (POLA) Stock Down 51% Today? (InvestorPlace) -44.52%
Nov-30-23 08:05PM Polar Power, Inc. Announces Pricing of Public Offering (GlobeNewswire)
05:25PM Polar Power, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Nov-28-23 08:00AM POLAR POWER AWARDED FIRST PLACE FOR PRESENTATION AT THE GLOBAL TECHNOLOGY CONFERENCE DURING LPG WEEK 2023 IN ROME, ITALY (GlobeNewswire)
Nov-14-23 04:25PM Polar Power Reports 12% Growth in Revenue During Third Quarter 2023 Financial Results (GlobeNewswire) +7.14%
Nov-09-23 08:15AM Polar Power, Inc., C.E.O. Arthur Sams, to Present at the 35th World LPG Forum Highlighting Cost and Environmental Benefits of Transitioning from Diesel to LPG in Multiple Markets (GlobeNewswire)
Nov-07-23 03:24PM (Updated) Polar Power Announces New 27KW Summit Series Deliveries to Tier-1 Telecom Customers (GlobeNewswire)
08:00AM Polar Power Announces New 27KW Summit Series Deliveries to Tier-1 Telecom Customers (GlobeNewswire)
Oct-27-23 08:00AM Polar Power Inc. Engages CORE IR for Investor Relations and Shareholder Communications Services (GlobeNewswire)
Aug-14-23 04:20PM Polar Power Reports Second Quarter 2023 Financial Results (GlobeNewswire)
ALT - Altimmune Inc - Stock Price Chart
TickerALT [NASD, RUT]
CompanyAltimmune Inc
CountryUSA
IndustryBiotechnology
Market Cap191.82MEPS (ttm)-1.54
P/E-EPS this Y18.02%
Forward P/E-EPS next Y-12.89%
PEG-EPS past 5Y56.82%
P/S685.06EPS next 5Y-
P/B1.25EPS Q/Q19.22%
Dividend-Sales Q/Q18000.00%
Insider Own1.01%Inst Own56.67%
Insider Trans-0.44%Inst Trans16.78%
Short Float12.65%EarningsNov 07/b
Analyst Recom1.00Target Price21.29
Avg Volume1.28M52W Range2.09 - 17.17
Dec-01-23 11:45AM Why Is Altimmune (ALT) Stock Up 43% Today? (InvestorPlace) +12.97%
04:47AM Altimmune, seeking edge on Lilly and Novo, puts heart health at center of phase 2 obesity data drop (FierceBiotech.com)
Nov-30-23 04:24PM Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide (GlobeNewswire)
Nov-08-23 09:15AM Altimmune, Inc. (NASDAQ:ALT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:00AM Altimmune Announces Third Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Oct-31-23 07:30AM Altimmune to Report Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 (GlobeNewswire)
Oct-26-23 07:30AM Altimmune Granted Fast Track Designation by FDA for Pemvidutide for the Treatment of Non-Alcoholic Steatohepatitis (NASH) (GlobeNewswire)
Oct-25-23 07:30AM Altimmune to Present New Data on the Anti-Inflammatory and Anti-Fibrotic Properties of Pemvidutide in a Late-Breaking Presentation at The Liver Meeting 2023 (GlobeNewswire)
Oct-17-23 07:30AM Altimmune to Participate at Two Upcoming Investor Conferences (GlobeNewswire)
Sep-26-23 07:30AM Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 59th Annual Meeting of the European Association for the Study of Diabetes (GlobeNewswire)
JHMB - John Hancock Mortgage-Backed Securities ETF - Stock Price Chart
TickerJHMB [NYSE]
CompanyJohn Hancock Mortgage-Backed Securities ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend4.27%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume7.90K52W Range20.20 - 22.07
BIOR - Biora Therapeutics Inc - Stock Price Chart
TickerBIOR [NASD]
CompanyBiora Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap32.00MEPS (ttm)-9.59
P/E-EPS this Y-26.33%
Forward P/E-EPS next Y74.58%
PEG-EPS past 5Y48.29%
P/S1599.75EPS next 5Y-
P/B-EPS Q/Q-614.96%
Dividend-Sales Q/Q-100.00%
Insider Own5.73%Inst Own50.36%
Insider Trans0.00%Inst Trans8.29%
Short Float2.93%EarningsNov 13/a
Analyst Recom1.00Target Price19.87
Avg Volume240.75K52W Range1.18 - 7.68
Nov-30-23 04:48PM Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis (GlobeNewswire)
Nov-14-23 09:37AM Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:01AM Q3 2023 Biora Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 04:05PM Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-06-23 08:00AM Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire) -9.52%
Oct-30-23 04:05PM Biora Therapeutics Submits Updated IND Application for BT-600 (GlobeNewswire)
Oct-23-23 05:30PM Biora Therapeutics to Submit Updated IND Application for BT-600 (GlobeNewswire) -6.87%
Oct-18-23 05:25AM BIOR: Precision Release Surgical Strike on the GI Tract (Zacks) +16.67%
Oct-05-23 08:00AM Biora Therapeutics Presents Data on the BioJet Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes (GlobeNewswire)
Sep-25-23 08:00AM Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program (GlobeNewswire)
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.